Literature DB >> 19197594

An 18-year follow-up of patients admitted to methadone treatment for the first time.

Ingrid Davstad1, Marlene Stenbacka, Anders Leifman, Anders Romelsjö.   

Abstract

An 18-year addiction career, 1985-2003, for 157 heroin dependent subjects (73% men; 49% human immunodeficiency virus seropositive) admitted for the first time to Stockholm's Methadone Maintenance Treatment program during 1989 to 1991 was analyzed with data from seven official registers and patient records. Regression analyses and incidence rates for various outcomes were calculated for subjects in first methadone maintenance treatment at the end of the observation period, discharged from first methadone maintenance treatment, in second methadone maintenance treatment, and discharged from second methadone maintenance treatment. Being human immunodeficiency virus positive (HR = 3.8), lodging (HR = 1.9) and prison sentence (HR = 1.7) predicted mortality for the 45% deceased. Approximately 70% of living subjects participated in methadone maintenance treatment at some period each year. Subjects in first or second methadone maintenance treatment had less criminality and had spent more time in methadone maintenance treatment (70% to 100%) than those discharged from first or from second methadone maintenance treatment (50%). Efforts and interventions should be intensified to increase time in treatment also for those with high problem severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197594     DOI: 10.1080/10550880802544997

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  5 in total

1.  Methadone use among HIV-positive injection drug users in a Canadian setting.

Authors:  Tyler Pettes; Evan Wood; Silvia Guillemi; Calvin Lai; Julio Montaner; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2010-07-03

2.  Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.

Authors:  Iuliia Makarenko; D C Ompad; Y Sazonova; T Saliuk; J DeHovitz; L Gensburg
Journal:  J Urban Health       Date:  2017-02       Impact factor: 3.671

3.  A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Eur J Epidemiol       Date:  2017-12-12       Impact factor: 8.082

4.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Authors:  R Douglas Bruce
Journal:  Int J Drug Policy       Date:  2010-03

5.  Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky.

Authors:  Jack Stone; Hannah Fraser; April M Young; Jennifer R Havens; Peter Vickerman
Journal:  Int J Drug Policy       Date:  2020-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.